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Toward a New
Understanding 
of Aging
By the year 2050, 21% of the U.S. popula-
tion will be age 65 or older, according to
the Population Reference Bureau. As our
bodies age, our ability to defend against
environmental insults diminishes, and
exposures can accelerate the aging process
and trigger or exacerbate disease. Decreased
efficiency in the blood–brain barrier and
the cardiovascular, pulmonary, immune,
musculoskeletal, hepatic, renal, and gas-
trointestinal systems can alter response to
environmental agents, leading to height-
ened susceptibility to the toxic effects of air
pollution, pesticides, and other exogenous
threats to health. Age-related physiologic
changes may also contribute to the release
of stored toxicants in the body such as
lead or organochlorines. Further, life-
long exposure to low-level toxicants
can increase the risk of diseases
common in the elderly, such as
osteoporosis, hypertension,
renal impairment, Parkinson
disease (PD), and Alzheimer
disease (AD).
Recognizing the urgency
of protecting the health of
older Americans, in 2002 the
U.S. Environmental Protec-
tion Agency (EPA) launched
the Aging Initiative, an infor-
mation- and recommendation-
gathering effort designed to
shape a planned National Agenda
for the Environment and the Aging
(for more information on this initia-
tive, see “Aging Research: The Future
Face of Environmental Health,” p. A760
this issue). The NIEHS is one of several
organizations actively participating in and
contributing to this initiative. At a
National Academy of Sciences workshop
titled Differential Susceptibility of Older
Persons to Environmental Hazards, held
5–6 December 2002 to help shape the
agenda, deputy director Samuel Wilson
was enthusiastic in his support for the
effort. “Our institute is very excited that
the U.S. EPA has taken on this topic as
an initiative,” he said. “[The NIEHS has]
a substantial interest in aging-related
research.”
Substantial interest generates substan-
tial investment. Wilson informed the
workshop participants that in the areas of
neurotoxicology, neurodevelopment, res-
piratory disease, cancer, and other chronic
diseases involving a relationship between
age and environmental exposure, the insti-
tute’s aging-related research portfolio
numbers approximately 50 projects with
funding of nearly $10 million dollars. He
added, “There is a substantial research
effort in inherited diseases that are associ-
ated with advances in aging and with
abnormalities in stress response.” The
research portfolio in that area consists of
about 75 projects, with expenditures
roughly the same as in the specific age-
related portfolio. Together, these invest-
ments represent about 5% of the institute’s
overall research portfolio.
Although there is no NIEHS program
specifically dedicated to addressing aging
and the environment, the institute’s com-
mitment to investigation of the complex
interplay between the two runs deeper than
grant making—it is an integral element of
the stated mission of the NIEHS. 
“We really look at things across a life
span,” says Anne Sassaman, director of the
NIEHS Division of Extramural Research
and Training. “With some things, we put a
lot of emphasis on the early stages of repro-
duction and development, but a lot of
those conditions then continue and may be
expressed at older ages as a result of . . . age
and time,” she says. “So aging is certainly
one of the key components of how we look
at our research programs.”
Studying the Aging Process
In 1996, an NIEHS research group led by
J. Carl Barrett (now director of the Center
for Cancer Research at the National
Cancer Institute) documented the first evi-
dence that aging of cells in culture is an
inherently genetically controlled process.
Today, two groups within the NIEHS are
exploring the so-called mitochondrial theo-
ry of aging—the idea that the aging process
itself may be due to a lifetime of oxidative
damage to proteins, DNA, and lipids in
mitochondria, the cellular organelles where
food is converted into energy. Senior staff
fellow William Copeland and the
Mitochondrial Replication Group are
addressing the origin of spontaneous muta-
tions in mitochondrial DNA by investigat-
ing the accuracy of replication machinery
needed to copy the mitochondrial DNA,
which consists of 16,569 base pairs that
encode for 13 proteins required for the
site’s operation. Adjunct investigator
Bennett Van Houten and the DNA
Repair/Mitochondrial Damage Group are
studying the consequences of damage
to mitochondrial DNA, which aside
from aging itself could include
links to age-related degenerative
diseases such as cancer, AD,
PD, and heart disease.
Scientists believe that
oxidative stress due to over-
production of free radicals
and/or the diminution of
protective mechanisms is
involved in the pathophysiol-
ogy of several diseases and
aging. Environmental expo-
sures have been shown to con-
tribute to increased generation
of such oxidants. Ronald Mason’s
Free Radical Metabolism Section
pioneered a free radical detection
and identification technique, electron
spin resonance, to investigate the molecu-
lar mechanisms involved in oxidative stress.
Mason’s group is also exploring strategies
for measurement of this potentially useful
biomarker in humans for clinical diagnosis.
NIEHS grantee Qin Chen, an assistant
professor of pharmacology and toxicology
at The University of Arizona, is also
researching the role of oxidative stress in
aging. His group has discovered several new
molecular targets altered by oxidants, focus-
ing currently on the p21WAF1/Cip1 gene.
Gaining knowledge about these targets and
how they are affected by oxidants may
advance understanding of aging and its
associated diseases.
Acquired genomic changes are believed
to play a role in aging and diseases such as
cancer. Colleen Jackson-Cook, an associ-
ate professor of genetics at Virginia
Commonwealth University, is beginning
to assess the extent to which individual
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differences between twins in acquired
chromosomal abnormalities, as well as
chromosome-specific telomere lengths, are
determined by genetic predisposition or
environmental factors. Jackson-Cook says
a clearer delineation of the observed varia-
tion in those anomalies and the factors
contributing to them “will be helpful for
designing tests to screen for individual dif-
ferences in susceptibility to change in the
human genome” and possibly predisposi-
tion tests for age-related maladies such as
cancer, ulcerative colitis, and AD.
NIEHS grantee Howard Hu, a profes-
sor of occupational and environmental
medicine at the Harvard School of Public
Health, has been working with samples and
data from the Normative Aging Study, a
cohort of adults who have been followed
for 40 years. Hu reports that his group’s
most recent analyses have shown that sub-
jects with an ALAD 2 genetic allele experi-
ence a greater toxic effect of lead on their
kidneys, and that subjects with a higher
body burden of lead have a greater risk of a
host of disorders, including anxiety, depres-
sion, myocardial infarction, hearing loss,
and cataracts. Most disturbingly, perhaps,
the subjects with higher environmental
lead burdens also manifested a steeper
decline in cognitive function with aging.
The effects of fine particle exposure on
cardiovascular function on susceptible
adults are being explored by NIEHS
grantees Diane Gold, an assistant profes-
sor of environmental health at the
Harvard School of Public Health, along
with co–principal investigators Doug
Dockery and Frank Speizer. A 1999 time-
series epidemiologic study involved repeat-
ed monitoring of 27 Boston adults aged
60–90 to evaluate whether measures of
cardiovascular function varied as air pollu-
tion fluctuated. The researchers discovered
a significant association between reduced
heart rate variability, an important mea-
sure of cardiac function, and elevated
ambient levels of fine particulate matter
and ozone, implying that exposure to
these pollutants may decrease vagal tone,
resulting in reduced heart rate variability.
A similar study conducted the following
year by the same group included measures
of indoor home exposure and personal
exposure to particles. Those results are
being prepared for publication.
Three ongoing grants seek explanations
for disparities in health and functionality
among seniors. Carlos Mendes de Leon, an
associate professor at Rush-Presbyterian-St.
Luke’s Medical Center in Chicago, is
examining the factors behind social and
racial inequalities in health among older
adults, focusing on disability and decline
in physical function as markers of overall
health status. Mendes de Leon and his
group hypothesize that older persons of
lower socioeconomic status and older
blacks experience increased risk of disabili-
ty due to greater exposure to biologic risk
factors and to adverse social and environ-
mental conditions. They are now in the
third year of collecting data on disability
status in a population of 6,000 subjects liv-
ing in the Southside area of Chicago, along
with detailed assessment of neighborhood
conditions. 
Brian Schwartz, director of the Division
of Occupational and Environmental
Health at The John Hopkins University,
and colleagues are engaged in the Baltimore
Memory Study, a multilevel cohort study
of the determinants of cognitive decline in
50- to 70-year-old residents of specific
neighborhoods in Baltimore, seeking to
quantify and analyze disparities in cognitive
functioning by race and ethnicity. Risk fac-
tors to be evaluated include environmental
agents such as lead and mercury, genetic
polymorphisms, health and cardiovascular
factors, social and behavioral factors, and
neighborhood contextual factors, which
include measures such as community
socioeconomic status, neighborhood ser-
vices, physical condition of buildings, and
social integration. According to Schwartz,
the study “represents a case study in multi-
level, multidisciplinary research aimed at
integrating knowledge within and across
biologic, environmental, social, behavioral,
and mathematical sciences.”
Neighborhood context is more of a pri-
mary focus in a study being conducted by
José Szapocznik, a professor of psychiatry
and behavioral sciences at the University of
Miami, on the built environment and
Hispanic elders’ behavioral health as mea-
sured by cognitive functioning, emotional
functioning, and individual and social
activity. He and his group are investigating
how and to what extent the architectural
features of the built environment that sup-
port social connectedness, such as the pres-
ence of a front porch and sidewalks, impact
elders’ behavioral health. According to
Szapocznik, it is “the first NIH study that
has recognized the neighborhood built
environment as a potential risk factor.”
Having assessed the baseline cognitive
functioning of 260 Hispanic elders in
Miami’s East Little Havana community,
the group will retest the subjects annually
for three years. They will then perform lon-
gitudinal analysis to examine whether built
environment variables influence social
behaviors and, as a result, impact the future
magnitude and direction of changes in
elders’ cognitive and affective functioning.
Neurodegenerative Diseases
The role of the environment in aging-relat-
ed neurodegenerative diseases such as PD,
AD, and amyotrophic lateral sclerosis
(ALS) has long been an area of particular
interest to the NIEHS. Recent initiatives
have stimulated a great deal of recent
research activity in the quest to delineate
how genetic susceptibility, environmental
exposures, and aging interact to trigger
these often devastating disorders.
PD. To accelerate the rate of progress
in PD research, in August 2002 the
NIEHS awarded grants establishing the
Collaborative Centers for Parkinson’s Dis-
ease Environmental Research (CCPDER)
program. CCPDER is a five-year, $20
million cooperative agreement in which
three multidisciplinary centers, in partner-
ship with the NIEHS, share data, ideas,
and resources. The centers are located at
Emory University, the University of
California, Los Angeles, and The Parkin-
son’s Institute in Sunnyvale, California.
Each program is designed to be multidis-
ciplinary, integrating clinical, epidemio-
logic, and basic science, while actively
coordinating efforts and collaborating
with colleagues at the other centers and
the institute. A steering committee over-
sees the collaborative activities among the
three centers.
The first year of the program has been
a building process, strengthening the col-
laborative relationships between groups
within each of the centers and beginning
to build effective partnerships between
centers. NIEHS CCPDER science admin-
istrator Cindy Lawler says the progress is
encouraging: “Our investigators are enthu-
siastic about the potential benefits of work-
ing together as a network of centers. By
sharing with each other findings that are
emerging, center investigators can more
quickly react to new findings, including
making adjustments in each of their
research programs to reinforce or extend
the findings of their colleagues.”
The objectives of this effort to jump-
start scientific progress on the world’s second
most common neurodegenerative disorder
are ambitious. “This program was built on
the premise that PD reflects an interaction
between genetic susceptibility and envi-
ronmental factors,” says Lawler. “So the
goal of the program is to identify and
understand these gene–environment
interactions, and then rapidly translate
that knowledge into the public health
domain. This translation could involve
identification of new targets for drug
therapy or recommendations for reducing
exposures to particular environmental
agents.” As a first step toward translation,the CCPDER is developing a website that
will include information describing each
of the CCPDER projects and their poten-
tial relevance to people with PD.
NIEHS-supported research into PD
extends well beyond the CCPDER pro-
gram. For example, Harvey Checkoway, a
professor of environmental and occupa-
tional health sciences at the University of
Washington, is pursuing a study of
gene–environment interactions in PD,
with an emphasis on exposures to indus-
trial solvents, heavy metals, and pesticides,
along with identification of genotypic risk
factors. The hypothesis of PD pathogene-
sis underlying his group’s investigation is
that chemicals that provoke oxidative
stress reactions destroy dopaminergic neu-
rons preferentially among persons with
genetically determined susceptibilities.
Checkoway says, “Our study findings to
date . . . are suggestive of potentially
important relations with dietary iron and
manganese.”
Deborah Cory-Slechta, director of the
Environmental and Occupational Health
Sciences Institute in Piscataway, New
Jersey, has shown that exposure to a com-
bination of pesticides—the fungicide
maneb and the herbicide paraquat—pro-
duces a PD-like condition, or PD pheno-
type, in an animal model. Exploring the
question of what other risk factors might
modulate this PD phenotype, she has
uncovered several potentially important
associations. 
First, age appears to be a significant risk
factor. “We took mice that were six weeks,
five months, and eighteen months of age,
and exposed them to this pesticide mix-
ture, and got marked effects, particularly
in the oldest animals,” says Cory-Slechta.
“There clearly is an aging component;
aging can enhance the effects of these
exposures.” Other experiments have shown
that genetic predisposition can modulate
the effects of the pesticide mixture, and
that developmental exposures can lead to
manifestation of the PD phenotype later in
life. “Not only that, but if you take a sub-
set of those animals and challenge them
again as adults, they show a very dramatic
PD phenotype,” she says. Her work could
have profound implications for risk assess-
ment questions regarding cumulative neu-
rotoxicity across the life span, sequential
exposures, and aging.
AD. Other grantees are investigating
environmental factors that are strongly
suspected to be involved in the pathogene-
sis of AD, another typically aging-related
neurodegenerative disorder. Exposure to
aluminum is falling under increasing
scrutiny as a risk factor. Stephen Bondy, a
professor of community and environmen-
tal medicine at the University of
California, Irvine, is examining the theory
that aluminum, although it has no intrin-
sic pro-oxidant properties, may enhance
the potential of transition metals such as
iron to enhance free radical generation in
nerve tissue. He reports that “our experi-
mental findings strengthen the possibility
that a prolonged exposure to relatively low
levels of aluminum may be neurotoxic.
The kinds of deficits that might be expect-
ed are not spectacular, but are likely to
involve subtle promotion of age-related
neurological disease.” 
Domenico Praticò, a research assistant
professor of pharmacology at the Univ-
ersity of Pennsylvania, has been investigat-
ing the effects of dietary aluminum on
amyloidosis, the formation of AD-like
plaque deposits, in the brains of transgenic
mice. His work, which has previously
shown that oxidative stress precedes the
onset of amyloid plaques, will elucidate the
role of aluminum as a modulator of brain
oxidative damage, and will examine the
hypothesis that vitamin E, a dietary antiox-
idant, could delay the onset of amyloid
plaque deposition in the animal model.
The potential relevance of mitochondr-
ial dysfunction caused by oxidative damage
in the pathophysiology of AD and other
neurodegenerative diseases is being investi-
gated by Yeong-Renn Chen, an assistant
professor of medicine at The Ohio State
University’s Davis Heart and Lung
Research Institute. He is concentrating on
identifying the molecular mechanisms
involved when an environmental insult
causes defects in two specific mitochondrial
enzymes, mitochondrial terminal enzyme
and mitochondrial cytochrome c.
Sterling Sudweeks, an assistant profes-
sor of physiology and developmental biol-
ogy at Brigham Young University, is
attempting to characterize a group of
receptors found in the hippocampus (an
area in the brain associated with learning
and memory) suspected of playing a role
in the development of dementia, one of
the tragic hallmarks of AD. Neuronal
nicotinic acetylcholine receptors
(nAChRs), the physiologic site of action
in the brain for nicotine, are also crucial to
hippocampal activity. They come in many
possible subtypes, and their expression can
be influenced by environmental exposures.
β-amyloid protein, which forms deposits
in the brains of AD patients, has been
shown to bind to and interfere with
synaptic signaling through neuronal
nAChRs. Sudweeks hopes that character-
izing the subtypes of neuronal nAChRs
will shed light on which tend to bind with
β-amyloid. This knowledge will help shed
light on how environmental exposures can
affect individual susceptibility to AD, and
ultimately could help identify targets for
therapeutic intervention.
Prostate Cancer
Of course, not all environmental expo-
sures are harmful. In fact, some seem to
impart a protective effect against other
sources of damage. That’s the core of the
theory behind senior scientist Coral
Lamartiniere’s study of prostate cancer at
the University of Alabama at Birmingham.
His group has discovered that dietary
exposure to genistein (a phytoestrogen
component of soy) starting at puberty
suppressed the development of sponta-
neous prostate cancer in transgenic mice
bred to be highly susceptible to the dis-
ease. That laboratory observation corre-
lates with other findings that Asian men
who consume a traditional diet high in
soy products have a low incidence of
prostate cancer. 
Lamartiniere hypothesizes that this
reduced susceptibility to prostate cancer is
dependent on a process called “imprint-
ing.” In imprinting, the consumption of
genistein at a particular time of develop-
ment—in transgenic mice this time was
before or at the onset of puberty—deter-
mines the biochemical blueprint of how
the prostate will respond later in life to
hormone and growth factor stimuli, which
can trigger cancer.
Imprinting of the prostate can appar-
ently also render an individual more sus-
ceptible to prostate cancer in his adult
years. Gail Prins, an associate professor in
the University of Illinois at Chicago
Department of Urology, has shown that
brief exposure of rodents to high doses of
natural or synthetic estrogens during
development results in permanent alter-
ations in growth and differentiation of
the prostate gland. This estrogen imprint-
ing is associated with prostatic lesions and
cancer later in life. Estrogen imprinting
could sensitize males to later estrogen
exposures, increasing susceptibility to
estrogen-induced prostatic tumors.
Because estrogen levels rise in the aging
male, this “two-hit” scenario could help
explain the high incidence of prostate
cancer in older men. Prins’s group is
exploring this scenario in animal models,
and investigating the genetic basis of the
suspected estrogen imprinting.
Osteoporosis
J. Edward Puzas, the Donald and Mary
Clark Professor of Orthopedics at the
University of Rochester, directs a program
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projects, each with its own principal inves-
tigator. The unifying hypothesis for the
program is that lead adversely affects
skeletal metabolism in children and adults
to the point that it is a causative factor in
bone diseases, especially osteoporosis. The
program aims to integrate basic science
findings on the effects of lead on the skele-
ton with the clinical entities of osteoporosis
and osteoporotic fractures. The group’s
preliminary data in both in vitro and in
vivo models suggest, Puzas says, that a sig-
nificant portion of people with osteoporosis
may have the disease due to lead exposure,
and that lead in the skeleton will prevent
normal healing of fractures. 
One of the team’s projects is intended
to translate knowledge gained from the
basic research projects into clinical diag-
nostic and therapeutic trials. They plan to
develop a clinical therapeutic paradigm
that will take bone lead burden into
account as an important factor in the
treatment of osteoporosis.
Lead exposure also figures prominently
in a study being conducted by Susan
Korrick, a lecturer in occupational health
at Brigham and Women’s Hospital in
Boston. Her objective is to study the
effects of environmental lead exposures
and allelic variants of the vitamin D recep-
tor on the development of osteoporosis in
middle-aged women. Preliminary results
support the hypothesis that increased bone
lead is associated with prospective decreas-
es in bone mineral density and increased
bone turnover activity, both of which are
risk factors for osteoporosis. Korrick
believes that polymorphisms in the vitamin
D receptor genotype may be responsible
for increased susceptibility to the disease,
and that lead exposure may be involved in
triggering or accelerating the skeletal
changes associated with osteoporosis.
The above compendium represents
just a small fraction of the aging-related
environmental health research taking place
both within the NIEHS and with its sup-
port. Wilson was, if anything, understat-
ing the case when he told the December
workshop participants that “certainly this
is an area that we at NIEHS have been
interested in for some time.”
Scientists may never discover a way to
halt or reverse the aging process. But with
the breadth and depth of aging-related
research going on at the NIEHS and else-
where, it seems likely that substantial
progress can be expected in the quest to
prevent and treat diseases associated with
aging, and to ensure that the environmen-
tal contribution to aging is restricted to
the normal and the natural. –Ernie Hood
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Headliners Reproductive Toxicants
DDT and DDE: Effect on Second Generation Time to Pregnancy
Cohn BA, Cirillo PM, Wolff MS, Schwingl PJ, Cohen RD, Sholtz RI, Ferrara A, Christianson RE,
van den Berg BJ, Siiteri PK. 2003. DDT and DDE exposure in mothers and time to pregnancy in
daughters. Lancet 361:2205–2206.
Reproductive tract anomalies have been seen in daughters of women who took the
potent estrogenic chemical diethylstilbestrol during pregnancy to prevent morning sick-
ness. Knowing this, NIEHS grantee Barbara Cohn at the Public Health Institute in
Berkeley, California, and colleagues decided to investigate whether in utero exposure
to weakly estrogenic chemicals, including the insecticide DDT and its metabolites, might
produce similar adverse reproductive effects. 
The World Health Organization estimates that during the period of DDT’s use
approximately 25 million lives were saved, predominantly from malaria and typhus.
However, many species of insects developed resistance to DDT, it proved to be highly
toxic toward fish, and it was responsible for the near-extinction of several bird species
because of its interference with the formation of egg shells. For these reasons and
because of its environmental persistence, the use of DDT was banned in the United
States in 1972. However, DDT is still used in some parts of the world.
In mammals, DDT and its major metabolite, DDE, persist in the body and are stored
in fat tissue. DDT is known to have weak estrogenic activity, and DDE has considerable
antiandrogenic activity. They can cross the placenta, potentially interfering with fetal
development. 
To further investigate possible effects on the human reproductive system, Cohn’s
team measured DDT and DDE concentrations in maternal serum samples collected dur-
ing 1960–1963. The samples were collected within 1–3 days of delivery from women
enrolled in the Kaiser Permanente health plan who were participating in the Child
Health and Development Studies. The researchers then compared these levels to the
time until pregnancy (measured by survey) for 289 daughters of these women.
There was a clear association between increased DDT concentrations in maternal
blood and a decreased chance of pregnancy in the daughters. For every 10 milligrams
per liter of DDT in maternal serum, the probability of pregnancy dropped 32%.
However, quite unexpectedly, the chance of pregnancy increased 16% with each
increase of 10 milligrams per liter of DDE. 
The opposing effects of DDT and DDE may explain why large changes in reproduc-
tive performance overall have not been noticed in humans since the introduction of
DDT. Although the decreased fertility associated with in utero exposure to DDT remains
unexplained, the authors speculate that the “antiandrogenic effects of DDE may miti-
gate harmful androgenic effects on the ovary during gestation and early life.” 
This study, the first to link DDT exposure in utero to human reproductive problems
some 30 years later, demonstrates the long delay from exposure to noticeable effect.
The findings support the establishment of new long-term human studies that can moni-
tor the effects of environmental exposures on reproduction, as well as continued sup-
port of existing studies where multigenerational follow-up is in progress. –Jerry Phelps
NIEHS-Supported Research
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